Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial. - Calais,G.; Bardet,E.; Sire,C.; Alfonsi,M.; Bourhis,J.; Rhein,B.; Tortochaux,J.; Man,Y.T.; Auvray,H.; Garaud,P. (Int J Radiat Oncol Biol Phys, 2004)